TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

(2019) Philipp Harter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

(2018) Pedro T. Ramirez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

(2015) Sean Kehoe et al.   LANCET

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

(2015) Amit M Oza et al.   LANCET ONCOLOGY

Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

(2013) Roberta De Angelis et al.   LANCET ONCOLOGY

Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials

(2012) S. Mahner et al.   EUROPEAN JOURNAL OF CANCER

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

(2012) Ignace Vergote et al.   GYNECOLOGIC ONCOLOGY

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer

(2011) Philipp Harter et al.   GYNECOLOGIC ONCOLOGY

Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer

(2010) L. Woelber et al.   EJSO

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

(2010) Ignace Vergote et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

(2009) Andreas du Bois et al.   CANCER